Networking sessions should involve a diverse group of participants including:
Researchers: Scientists investigating the molecular mechanisms of cancer. Clinicians: Healthcare providers who treat cancer patients. Patients and advocates: Individuals who provide a unique perspective on patient needs and experiences. Policy makers: Those who influence cancer research funding and healthcare policies. Industry representatives: Individuals from pharmaceutical and biotech companies developing new cancer therapies.
